Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

345 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Accuracy of serological testing for SARS-CoV-2 antibodies: First results of a large mixed-method evaluation study.
Brigger D, Horn MP, Pennington LF, Powell AE, Siegrist D, Weber B, Engler O, Piezzi V, Damonti L, Iseli P, Hauser C, Froehlich TK, Villiger PM, Bachmann MF, Leib SL, Bittel P, Fiedler M, Largiadèr CR, Marschall J, Stalder H, Kim PS, Jardetzky TS, Eggel A, Nagler M. Brigger D, et al. Among authors: bachmann mf. Allergy. 2021 Mar;76(3):853-865. doi: 10.1111/all.14608. Epub 2020 Nov 13. Allergy. 2021. PMID: 32997812 Free PMC article.
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2.
Mohsen MO, Balke I, Zinkhan S, Zeltina V, Liu X, Chang X, Krenger PS, Plattner K, Gharailoo Z, Vogt AS, Augusto G, Zwicker M, Roongta S, Rothen DA, Josi R, Costa JJD, Sobczak JM, Nonic A, Brand LA, Nuss K, Martina B, Speiser DE, Kündig T, Jennings GT, Walton SM, Vogel M, Zeltins A, Bachmann MF. Mohsen MO, et al. Among authors: bachmann mf. Allergy. 2022 Jan;77(1):243-257. doi: 10.1111/all.15080. Epub 2021 Sep 20. Allergy. 2022. PMID: 34496033 Free PMC article.
The Future of SARS-CoV-2 Vaccination.
Bachmann MF, Mohsen MO, Speiser DE. Bachmann MF, et al. N Engl J Med. 2022 Mar 3;386(9):899. doi: 10.1056/NEJMc2119437. N Engl J Med. 2022. PMID: 35235737 No abstract available.
Intranasal administration of a virus like particles-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern.
Rothen DA, Krenger PS, Nonic A, Balke I, Vogt AS, Chang X, Manenti A, Vedovi F, Resevica G, Walton SM, Zeltins A, Montomoli E, Vogel M, Bachmann MF, Mohsen MO. Rothen DA, et al. Among authors: bachmann mf. Allergy. 2022 Aug;77(8):2446-2458. doi: 10.1111/all.15311. Epub 2022 Apr 15. Allergy. 2022. PMID: 35403221 Free PMC article.
345 results